• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Regulus Therapeutics (NQ: RGLS )

    1.650 -0.050 (-2.94%)
    Streaming Delayed Price Updated: 12:26 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 131,037
    Open 1.710
    Bid (Size) 1.650 (6)
    Ask (Size) 1.660 (17)
    Prev. Close 1.700
    Today's Range 1.630 - 1.760
    52wk Range 1.080 - 3.790
    Shares Outstanding 87,040,335
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    What's Going On With Regulus Therapeutics Stock Monday?
    Regulus Therapeutics announced positive results from its study related to the treatment of autosomal dominant polycystic kidney disease (AKPD). 
    Via Benzinga

    Performance

    YTD
    +25.95%
    +25.95%
    1 Month
    -30.38%
    -30.38%
    3 Month
    -29.49%
    -29.49%
    6 Month
    +46.02%
    +46.02%
    1 Year
    +13.79%
    +13.79%

    More News

    Read More
    RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Analyst Expectations for Regulus Therapeutics's Future
    Via Benzinga
    Expert Ratings for Regulus Therapeutics
    Via Benzinga
    RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
    Via AB Newswire
    Gold Down Over 1%; ClearOne Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks
    Via Investor Brand Network
    Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.